Sign in

Ajei Gopal

Director at SYNOPSYSSYNOPSYS
Board

About Ajei Gopal

Appointed to the Synopsys board on July 17, 2025 in connection with the completion of the Ansys acquisition; he joined as a non-employee director subject to Synopsys’ standard director program (cash retainer and RSUs) and standard indemnification agreement . He served as President & CEO of Ansys (2017–2025), previously as President & COO (2016), was an operating partner at Silver Lake (2013–2016, including a secondment as Symantec interim President & COO in 2016), and earlier a Senior Vice President at Hewlett Packard Enterprise (2011–2013) . External governance roles include director of Fiserv, Inc. (since 2024) and trustee of Carnegie Mellon University (since 2022); prior public board service includes Citrix (2017–2021) .

Past Roles

OrganizationRoleTenureCommittees/Impact
Ansys, Inc.President & CEO; previously President & COOCEO 2017–2025; P/COO 2016Led the company through sale to Synopsys; brings systems simulation leadership for post-merger integration
Silver LakeOperating Partner2013–2016PE operating leadership; seconded to Symantec as interim P/COO in 2016
Symantec (now Gen Digital)Interim President & COO (secondment from Silver Lake)2016Executive transition/operations leadership
Hewlett Packard EnterpriseSenior Vice President2011–2013Enterprise tech operating experience

External Roles

OrganizationRoleTenureNotes
Fiserv, Inc.Director2024–presentCurrent public company directorship
Carnegie Mellon UniversityTrustee2022–presentHigher-education board role
Citrix SystemsDirector2017–2021Prior public company board experience

Board Governance

  • Synopsys appointment: Board size increased from nine to eleven at closing of the Ansys deal; Gopal and Ravi Vijayaraghavan were appointed pursuant to the merger agreement effective July 17, 2025 .
  • Committees: At appointment, Gopal was not assigned to any Synopsys board committees . The proxy details committee composition as of the April 10, 2025 annual meeting (pre-acquisition) and post-meeting roles, but does not yet include Gopal on any committee .
  • Independence and conflicts: Non-employee director; no family relationships with Synopsys directors/executives and no material related-party transactions requiring disclosure under Item 404(a) at appointment .
  • Indemnification: Entered Synopsys’ standard director indemnification agreement (form filed previously) .
  • Board attendance context: Synopsys’ board held six meetings in fiscal 2024 and each then-serving director attended >75% of board/committee meetings; this predates Gopal’s appointment .
  • Stockholder oversight context: 2025 annual meeting results included approval of say‑on‑pay and equity plan amendments; board leadership updates included a new Lead Independent Director post‑meeting .

Fixed Compensation (Synopsys Non‑Employee Director Program)

ElementAmount/TermsSource
Annual cash retainer (Board)$125,000, paid in advance quarterly; prorated in first year
Lead Independent Director fee+$30,000 per year (context, not specific to Gopal)
Committee Chair feesAudit Chair +$40,000; Comp Chair +$25,000; Gov Chair +$25,000
Committee member feesAudit member +$15,000; Comp member +$10,000; Gov member +$10,000
Travel reimbursementReimbursed per Corporate Travel Policy

Notes: No per‑meeting fees. As of FY2025, Synopsys made no changes to non‑employee director compensation levels vs. FY2024 .

Performance Compensation (Equity; time‑based for Directors)

Award TypeValue/Grant PracticeVestingSource
Initial RSU (on appointment)$350,000 grant date fair valueVests in equal installments immediately before each of the first three annual meetings following grant, subject to continued board service
Interim RSU (if appointed between annual meetings)Pro‑rated portion of $200,000Vests immediately before the first annual meeting following grant
Annual RSU (recurring policy context)~$200,000 full‑value restricted stock (FY2024 example)Vests immediately before next annual meeting; in FY2024, directors received 356 shares each at $561.23 grant price

Policy highlights for director equity: full‑value, time‑based; no performance‑based equity for directors; robust stock ownership guidelines; hedging and pledging prohibited .

Other Directorships & Interlocks

CompanyTypeRolePotential Interlock/Conflict Consideration
Fiserv, Inc.PublicDirector (since 2024)No Synopsys‑specific related‑party transactions disclosed; monitor for any commercial relationships (none disclosed at appointment)
Carnegie Mellon UniversityNon‑profitTrustee (since 2022)None disclosed
Citrix SystemsPublic (prior)Director (2017–2021)Historical; no current interlock

Overboarding policy context: Synopsys limits executives of public companies to serve on no more than two public company boards including Synopsys; other independent directors may serve on up to four. Compliance for nominees is assessed annually; policy statement provided for context .

Expertise & Qualifications

  • Enterprise software and simulation leadership (Ansys CEO/COO; systems engineering and multiphysics simulation integration) .
  • Private equity operating experience (Silver Lake), enterprise software operations (HPE), and interim transformation leadership (Symantec) .
  • Public company board experience across technology sectors (Fiserv, Citrix) .

Equity Ownership

As‑Of DateInstrumentQuantity/DetailPost‑Txn HoldingsSource
July 17, 2025 (Form 3 event)Common Stock95,503 shares (direct)95,503
July 17, 2025 (Form 3)RSUs (time‑based; converted from Ansys)36,856; 6,009; 27,795; 46,596 (various schedules)N/A
July 31, 2025 (Form 4)RSU vesting and share withholding for taxes117,256 RSUs vested; 46,153 shares withheld at $633.47 for taxes; no open‑market salesDirect holdings increased to 166,606 shares

Policy notes: Synopsys prohibits director hedging and pledging of company stock; non‑employee directors are expected to reach stock ownership equal to 3x annual cash retainer or 15,000 shares within 3 years of initial election and maintain it thereafter (guidelines updated December 2023) .

Governance Assessment

Strengths

  • Strategic fit and integration expertise: Direct leadership of Ansys positions Gopal to enhance board oversight of silicon‑to‑systems integration post‑merger; appointment was contemplated by the merger agreement to support integration .
  • Clean conflicts profile at appointment: No family relationships; no Item 404(a) related‑party transactions; standard indemnification; participation in non‑employee director program indicates independence of role .
  • Alignment mechanisms: Time‑based director RSUs and stock ownership guidelines; hedging/pledging prohibitions; strong overall board governance practices (majority voting, independent committees) .

Watch items

  • Committee influence: No committee assignment at appointment; investors may watch for eventual placement (Audit/Governance/Compensation) to leverage operating expertise .
  • Overboarding monitoring: Synopsys policy limits executives of public companies to two public boards including Synopsys; Gopal also serves on Fiserv’s board. Continued compliance should be monitored alongside any future executive or board roles; policy framework provided for context .
  • Equity transitions: July 2025 RSU conversions/accelerations were M&A‑driven; Form 4 indicates tax withholding only with no open‑market sales, supportive of alignment and not a liquidity‑driven disposition .

Shareholder sentiment context

  • 2025 annual say‑on‑pay: For 113,853,659; Against 11,142,380; Abstain 1,171,317; broker non‑votes 12,427,073 (advisory approval) .
  • Governance engagements: Synopsys reports ongoing investor outreach and strong board refreshment processes, including lead independent director transition and committee compositions; context for investor confidence but not specific to Gopal .

Insider Trades (selected)

DateFilingTransactionSharesPriceResulting HoldingsNotes
2025‑07‑24Form 3Initial beneficial ownership on joining board95,503 common; RSUs: 36,856; 6,009; 27,795; 46,596N/A95,503 commonConverted Ansys awards to Synopsys RSUs per merger terms
2025‑07‑31Form 4RSU vesting; tax withholding only117,256 vested; 46,153 withheld$633.47 (withholding reference)166,606 commonNo open‑market sales reported

Related‑Party / Conflicts Review

  • At appointment, Synopsys disclosed no material related‑party transactions for Gopal, and no family relationships with directors/executives. He will receive standard non‑employee director compensation and standard indemnification .
  • Company‑wide, the Audit Committee oversees and pre‑approves related‑party transactions under a formal policy; none over $120,000 were reported from the beginning of FY2024 through the proxy’s publication, other than routine compensation .

Director Compensation Structure (context and 2024 levels)

ComponentFY2024 AmountNotes
Cash: Board retainer$125,000Paid quarterly in advance
Cash: Lead Independent Director+$30,000Role‑based
Cash: Committee ChairsAudit +$40,000; Comp +$25,000; Gov +$25,000Role‑based
Cash: Committee MembersAudit +$15,000; Comp +$10,000; Gov +$10,000Role‑based
Equity: Annual award~$200,000 restricted stockTime‑based vesting before next annual meeting; FY2024 example 356 shares at $561.23

Note: For FY2025, Synopsys made no changes to non‑employee director compensation levels vs. FY2024 . Gopal’s initial/interim RSU grants follow the 2025 8‑K terms shown above .

Equity Ownership & Alignment Policies

  • Non‑employee director ownership guideline: the lesser of 3x annual cash retainer or 15,000 shares, to be achieved within 3 years of initial election and maintained thereafter; directors are encouraged to retain a portion of vested shares to meet/maintain guidelines .
  • Hedging/Pledging: Policies prohibit hedging and pledging by directors .

Notes on Committee Landscape (pre‑Ansys close)

  • As of the April 10, 2025 annual meeting: Audit (Chair: Mercedes Johnson); Compensation (Chair: John G. Schwarz; Chair to transition to Robert G. Painter after the meeting); Governance (Chair: Janice D. Chaffin). These rosters did not yet include Gopal (appointed in July 2025) .

Citations

  • Appointment, compensation on joining, lack of related‑party interests, and background:
  • Indemnification agreement:
  • 2025 proxy governance, committee structures, director compensation framework, stock ownership guidelines, related‑party policy, board attendance context:
  • Annual meeting vote results (2025):
  • Form 3 (initial beneficial ownership upon joining Synopsys board):
  • Form 4 (RSU vesting/tax withholding):